Furthermore, understanding how tumor cells influence the immune microenvironment and interact with the blood vessel endothelium would help assess the effectiveness and bioavailability of immunotherapy drugs, such as PD-L1 inhibitors. The gene discussed is CD274; the disease is neoplasm.